Global Glycomics Market Overview 2024-2032
IMARC Group, a leading market research company, has recently releases report titled “Glycomics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032.” The study provides a detailed analysis of the industry, including the global glycomics market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
The global glycomics market size reached US$ 1.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 4.1 Billion by 2032, exhibiting a growth rate (CAGR) of 11.17% during 2024-2032.
Glycomics is the comprehensive study of glycomes, which are the entire set of sugars, whether free or present in more complex molecules, found in an organism. It aims to understand the structure, function, and interactions of carbohydrates within biological systems. It uses various techniques, such as mass spectrometry and chromatography, for the identification and analysis of complex sugar structures. It focuses specifically on the role of sugars in biological processes as compared to genomics and proteomics. It finds application in medicine, drug development, biomarker discovery, and personalized therapeutics.
Global Glycomics Market Trends and Drivers:
The growing prevalence of various chronic conditions, such as cancer and diabetes, among the masses represents one of the primary factors driving the need for more advanced diagnostic and therapeutic options like glycomics around the world. Moreover, the increasing financial commitment to life sciences and biomedical research, which includes the study of glycans, is favoring the growth of the market. In addition, the rising need for reliable biomarkers in diagnostics and therapeutic monitoring is contributing to the market growth. Apart from this, the growing number of collaborations and partnerships among biologists, chemists, and data scientists, along with the increasing number of clinical trials, and significant improvements in the healthcare infrastructure, is influencing the market positively.
Request a Sample Report:- https://www.imarcgroup.com/glycomics-market/requestsample
Global Glycomics Market 2024-2032 Analysis and Segmentation:
Top Key Players covered in this report are: Agilent Technologies Inc., Asparia Glycomics, Bruker Corporation, Danaher Corporation, Dextra Laboratories Limited (New Zealand Pharmaceuticals Limited), Merck KGaA, New England Biolabs, RayBiotech Life Inc., Shimadzu Corporation, Takara Bio Inc., Thermo Fisher Scientific Inc., Waters Corporation. etc.
The report segmented the market on the basis of region, component, product, type, delivery mode, model, and application.
Breakup by Product:
- Enzymes
- Glycosidases
- Glycosyltransferases
- Neuraminidases
- Sialyltransferases
- Others
- Instruments
- Mass Spectrometers
- HPLC
- MALDI-TOF
- Array systems
- Others
- Kits
- Glycan Labeling Kits
- Glycan Purification Kits
- Glycan Release Kits
- Others
- Reagents
- Glycoproteins
- Monosaccharides
- Oligosaccharides
- Others
Breakup by Application:
- Drug Discovery and Development
- Diagnostics
- Others
Breakup by End User:
- Academic and Research Institutes
- Pharmaceutical and Biotechnology Companies
- Contract Research Organizations (CROs)
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Key highlights of the report:
- Market Performance (2018-2023)
- Market Outlook (2024- 2032)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Services Private Limited.
134 N 4th St. Brooklyn, NY 11249, USA
Email: [email protected]
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
